Airs Medical vs Pearl
Airs Medical sells to neuroradiology and imaging groups, with SwiftMR for MRI reconstruction and SwiftSight for brain measurements tracked over time. SwiftMR was one of three protocols compared in a 2026 Scientific Reports study of T2-weighted liver MRI. For brain follow-up the relevant clearance is SwiftSight-Brain (K251483, September 2025), and SwiftSight-BodyComposition (K261612, October 2026) extends the line beyond the brain.
Pearl sells Second Opinion into dentistry, which makes it a tool for a different customer group from Airs's. Dental groups on Open Dental or Eaglesoft are the fit, two of the 40-plus integrations Pearl lists, along with DEXIS and Carestream. Pearl has eight openFDA decisions, from March 2022 to November 2025 (Second Opinion Panoramic), and its FAQ says it marks up to 18 findings per image. The vendor gives 23,000 to 29,000 practices. A 2026 Caries Research comparison of five commercial systems, Second Opinion among them, found sensitivity for secondary caries on bitewings ranging from 0.327 to 0.487 across the five.
Radiology · Reviewed November 2, 2026
Airs Medical
by AIRS Medical Inc.
FDA-cleared AI MRI reconstruction (SwiftMR) and quantification (SwiftSight) for imaging centers and radiologists.
Pearl
by Pearl Inc. · founded 2019
FDA-cleared dental x-ray AI (Second Opinion) that marks caries, bone loss and restorations, for dentists and DSOs.
When to pick each one
Airs Medical
- SwiftMR was one of three protocols in a liver MRI study
- Body-composition software cleared October 2026 (K261612)
Pearl
- Names DEXIS, Open Dental and Eaglesoft integrations
- Eight openFDA decisions, Panoramic cleared November 2025
Score
Each row shows points earned of points available under the published rubric.
Airs Medical
37of 100
Pearl
33of 100
| Dimension | Airs Medical | Pearl | Difference |
|---|---|---|---|
| FDA clearance | 18 / 18 | 18 / 18 | 0 |
| HIPAA / SOC2 / BAA | 0 / 10 | 0 / 10 | 0 |
| EHR integrations (count) | 0 / 4.2 | 0 / 4.2 | 0 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 0 / 2.4 | 0 |
| Peer-reviewed papers | 7.3 / 18.2 | 0 / 18.2 | +7.3 |
| RCT / meta-analysis / systematic review | 0 / 7.8 | 0 / 7.8 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 2.5 / 5 | 2.5 / 5 | 0 |
| Years in market | 0 / 6 | 4.2 / 6 | -4.2 |
Scroll horizontally to see every column.
Pricing
Airs Medical
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Pearl
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. |
Evidence
Airs Medical
FDA decisions
K261612 (opens in new tab)510(k)2026-10-01
SwiftSight-BodyComposition
K261349 (opens in new tab)510(k)2026-07-24
SwiftMR
K253775 (opens in new tab)510(k)2026-03-26
SwiftMR
K251483 (opens in new tab)510(k)2025-09-23
SwiftSight-Brain
K230854 (opens in new tab)510(k)2023-10-27
SwiftMR
Show 2 more
K220416 (opens in new tab)510(k)2022-05-25
SwiftMR
K210999 (opens in new tab)510(k)2021-10-14
SwiftMR
Peer-reviewed
1 PubMed record names Airs Medical.
Pearl
FDA decisions
K250525 (opens in new tab)510(k)2025-11-14
Second Opinion Panoramic
K243234 (opens in new tab)510(k)2025-06-12
Second Opinion CS
K243989 (opens in new tab)510(k)2025-05-23
Second Opinion 3D
K243230 (opens in new tab)510(k)2025-05-09
Second Opinion BLE
K243893 (opens in new tab)510(k)2025-05-05
Second Opinion Pediatric
Show 3 more
K242600 (opens in new tab)510(k)2025-04-11
Second Opinion Periapical Radiolucency Contours
K242522 (opens in new tab)510(k)2025-01-16
Second Opinion CC
K210365 (opens in new tab)510(k)2022-03-04
Second Opinion
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Airs Medical | Pearl |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Not specified |
| Founded | n/a | 2019 |
| HQ | KR | US |
Scroll horizontally to see both columns.
Common questions
Open the full radiology comparison
Acute-care triage, mammography screening, CCTA plaque analysis, mobile MRI. 30+ FDA-cleared platforms across stroke, oncology, cardiac. Enterprise sales only — we compared what's deployed where.